Showing results (21-30 of 324) with videos related to
Sort By:
Pageof 33
Yonsei Medical Journal|January 5, 2010
The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancerByoung Chul Cho, Joo Hang Kim, Ross A Soo, et al.Cancers|July 29, 2025
The Prognostic Role of Tertiary Lymphoid Structures and Immune Microenvironment Signatures in Early-Stage EGFR-Mutant Lung AdenocarcinomaWei-Hsun Hsu, Chia-Chi Hsu, Min-Shu Hsieh, et al.Therapeutic Advances in Medical Oncology|August 27, 2020
The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutationShang-Gin Wu, Chong-Jen Yu, James Chih-Hsin Yang, et al.Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutationsSheng-Kai Liang, Jen-Chung Ko, James Chih-Hsin Yang, et al.Lung Cancer (Amsterdam, Netherlands)|July 6, 2017
Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapyBin-Chi Liao, Chia-Chi Lin, Jih-Hsiang Lee, et al.JTO Clinical and Research Reports|November 3, 2022
Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement-Combination of EGFR Tyrosine Kinase Inhibitors and ALK InhibitorsMing-Hung Huang, Jih-Hsiang Lee, Pei-Shan Hung, et al.Clinical Lung Cancer|May 1, 2016
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non-Small-Cell Lung Cancer: Analysis and Literature ReviewYen-Ting Lin, Chong-Jen Yu, James Chih-Hsin Yang, et al.Therapeutic Advances in Medical Oncology|September 2, 2015
Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategyBin-Chi Liao, Chia-Chi Lin, Jin-Yuan Shih, et al.Cancers|April 5, 2020
The Inhibition of Wnt Restrain KRASG12V-Driven Metastasis in Non-Small-Cell Lung CancerPei-Shan Hung, Ming-Hung Huang, Yuan-Yeh Kuo, et al.Journal of Biomedical Science|December 4, 2016
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitorsBin-Chi Liao, Chia-Chi Lin, Jih-Hsiang Lee, et al.Pageof 33